Endpoints NewsAmarin claims a big win for its cardio outcomes study on Vascepa — and you can bet that makes some people very ...Endpoints NewsAmarin $AMRN has staked its claim to the next big blockbuster in the cardio space, heralding a clear statistical win on the primary endpoint for its 7-year clinical quest to prove that its industrial strength purified fish oil Vascepa can significantly ...In Blowout, Amarin's Fish-Oil-Derived Drug Dramatically Cuts Heart Risk In StudyForbesall 25 news articles »

BING NEWS:
  • Amarin falls on CEO exit and Vascepa coverage update
    In a regulatory filing on Tuesday, the Dublin, Ireland-based company said that the PBM would no longer cover Vascepa as its exclusive icosapent ethyl product in its commercial national formularies ...
    06/4/2024 - 5:10 am | View Link
  • Amarin CEO resigns, leaving former interim chief to take over struggling drugmaker
    The latter company argued that the launch of the drugmaker's sole product, fish oil-derived heart pill Vascepa, was “behind schedule” in Europe and eventually won out when seven Amarin board ...
    06/4/2024 - 12:19 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News